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Abstract
Objective: The prevalence of β-thalassemia  in Şanlıurfa province, Turkey is reported to be 2.6%-3.7%, 
whereas nation-wide the frequency of β-thalassemia is 2%. This study aimed to identify the most fre-
quent β-thalassemia mutations in Şanlıurfa province. 
Materials  and  Methods:  In  total,  22  mutations  were  investigated  in  115  pediatric  patients  with 
β-thalassemia using a commercially available reverse dot blot platform.
Results: The study included 60 male and 55 female patients with a mean age of 7.3±4.6 years (range: 
1-17 years). In total, 76% of the patients had consanguineous parents. In all, 16 different mutations were 
observed  in  the  115  patients.  IVS-1-110  (G-A)  (29.1%),  IVS-1-1  (G-A)  (13.9%),  codon  39  (C>T) 
(10.4%), and codon 8 (-AA) (9.1%) accounted for 62.5% of all the β-thalassemia mutations, and 6% of 
the patients had 2 different thalassemia mutations. According to the present results, IVS-1-110 (G>A) 
was the most frequent mutation observed in the patients from Şanlıurfa province, as in other geograph-
ical  regions  of  Turkey.  In  addition,  the  following  34  compound  heterozygote  mutant  alleles  were 
observed; IVS-1-1 (G>A)/IVS 2.848 (n=4), codon 39 (C>T)/codon 8 (-AA) (n=2), codon 6 (-A)/IVS 
1.5 (G>C) (n=2), IVS-1-110 (G>A)/IVS-1-1 (G>A) (n=2), IVS-1-110 (G>A)/codon 8 (-AA) (n=1), 
IVS-1-110 (G>A)/codon 39 (C>T) (n=1), IVS-1-110 (G>A)/IVS-1-6 (T>C) (n=1), IVS-1-110 (G>A)/
IVS-1-5 (G>C) (n=1), IVS-1-110 (G>A]/codon 8/9 (+G) (n=1), IVS-1-1 (G>A)/codon 39 (C>T) 
(n=1), and codon 8 (-AA)/IVS-1-5 (G>C) (n=1). The following β-globin gene promoter mutations were 
not observed; -101 (C>T), -87(C>T), -30 (T>A), codon 15 (TTG>TGA), codon 27 (G>T) Knossos, 
and IVS-1-116 (G>C). In all, 5 of the 115 patients (4.3%) had an unidentified mutation.
Conclusion: The present results illustrate the heterogeneity of β-thalassemia mutations in Şanlıurfa 
Province. The present findings may be of value for genetic counseling, and premarital and prenatal 
diagnosis in Şanlıurfa province. (Turk J Hematol 2011; 28: 264-8)
Key words: Beta-thalassemia, mutation, Şanlıurfa, Turkey
Received: January 12, 2011      Accepted: July 12, 2011 
TJH-ARALIK-2011-4-crossref.indd   16 02.12.2011   10:13Introduction
Although β-thalassemia is associated with >200 
mutations,  most  are  rare  [1].  Approximately  20 
common alleles constitute 80% of all known thalas-
semias  worldwide;  3%  of  the  world’s  population 
carries  genes  for  β-thalassemia.  The  overall  fre-
quency of β-thalassemia in Turkey is 2%, but within 
the country the rate differs significantly according to 
region. In particular areas of the country there are 
fewer common alleles. The highest frequencies of 
β-thalassemia  in  Turkey  are  observed  in  Antalya, 
Thrace (10% each), and Muğla (4.8%) [2]. The fre-
quency of β-thalassemia in Turkey is lowest in east-
ern  and  northern  Anatolia,  and  is  moderate  in 
southern Anatolia. 
β-thalassemia mutations are extremely heteroge-
neous [2-5]. It was reported that only 7 mutations 
comprise 67% of all β-thalassemia mutations [6,7]. 
Regional  differences  in  the  frequency  of  various 
mutations may offer clues regarding migration pat-
terns  and  the  ethnic  background  of  a  particular 
population [3,6]. It was previously reported that IVS-
1-110  (G-A),  codon  8  (-AA),  and  IVS-2-1  (G>A) 
mutations  were  present  in  28  of  51  patients  with 
β-thalassemia in Şanlıurfa Province, Turkey [8]. The 
present study aimed to determine the prevalence of 
22  mutations  in  115  patients  with  β-thalassemia 
from Şanlıurfa Province, Turkey, and which occurred 
most frequently. 
Materials and Methods
This study was conducted at Harran University, 
Education  and  Research  Hospital,  Pediatric 
Hematology outpatient clinic between March and 
May 2010. The study included 115 patients (60 male 
and 55 female) with a mean age of 7.3±4.6 years 
(range: 1-17 years). The Harran University Education 
and Research Hospital Ethics Committee approved 
the study protocol, and written informed consent 
was obtained from all the patients’ parents.
Blood  samples  were  collected  from  the 
β-thalassemia patients into EDTA tubes and brought 
to the laboratory in a cold chain. The place and date 
of birth, and the name of each patient were record-
ed.  Hematological  analysis  was  performed  the 
same day blood was collected using an automated 
cell counter (Cell Dyne 1700, Abbott Diagnostics). 
DNA was isolated via standard phenol-chloroform 
extraction and ethanol precipitation, and mutation 
analysis of the β-globin gene was performed using a 
commercially  available  reverse  dot  blot  platform 
(Beta-Globin  Strip  Assay,  Vienna  Lab,  Vienna, 
Austria).  Mutations  affecting  gene  transcription 
were -101 (C>T), -87 (C>G), and -30 (T>A), frame-
Özet
Amaç: Türkiye genelinde %2 olan beta-talasemi sıklığı Türkiye’nin güneydoğu bölgesinde yer alan 
Şanlıurfa ilinde %2.6-%3.7 arasında olduğu bulunmuştur. Bu çalışmada en sık gözlenen mutasyon 
tiplerini araştırdık.
Yöntem ve Gereçler: Bu çalışmada beta talasemili 115 çocuk hastada 22 adet mutasyon ticari ters dot 
blot seritler ile araştırıldı.
Bulgular: Vakaların 60'ı erkek 55’i kız, yaşları 2-17 (ortalama 7.3±4.6) yıl idi. 110 hastada 16 farklı 
mutasyon saptandı. IVS-1-110 (G-A) %29.1, IVS-1-1 (G-A) %13.9, codon 39 (C>T) %10.4, codon 8 
(-AA) %9.1 en sık olarak belirlendi ve bunların vakaların %62.5’ini oluşturduğu görüldü. Türkiye’nin 
diğer bölgelerinde olduğu gibi IVI-1-110 (G>A) en sık saptanan mutasyon olmuştur. Çalışmada IVS-
1-1 (G>A)/IVS 2.848 (4 vaka), codon 39 (C>T)/codon 8 (-AA) (2), codon 6 (-A)/IVS-1-5 (G>C) (2), 
IVS-1-110 (G>A)/IVS-1-1 (G>A) (2), IVS-1-110 (G>A)/codon 8 (-AA) (1), IVS-1-110 (G>A)/codon 
39 (C>T) (1), IVS-1-110 (G>A)/IVS-1-6 (T>C) (1), IVS-1-110 (G>A)/IVS-1-5 (G>C) (1), IVS-1-110 
(G>A)/codon 8/9 (+G) (1), IVS-1-1 (G>A)/codon 39 (C>T) (1), codon 8 (-AA)/IVS-1-5 (G>C) (1) 
adet olmak üzere 34 mutant alelin birleşik heterozigot mutasyon oluşturduğu saptandı. -101 (C>T), 
-87(C>T),  -30  (T>A),  codon  15  (TTG>TGA),  codon  27  (G>T)  Knossos  ve  IVS-1-116  (T>G) 
β-globin geni promoter bölgesi mutasyonları hiç bir hastada tesbit edilmedi. 5 (%4.3) hastanın mutas-
yonu saptanamadı. 
Sonuç:  Şanlıurfa  bölgesinde  β-talasemi  çok  çeşitli  mutasyonlarla  ortaya  çıkmaktadır.  Bu  sonuçlar 
genetik danışma ve doğum öncesi tanıda yardımcı olabilir. (Turk J Hematol 2011; 28: 271-5)
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mutation were codon 5 (-CD), codon 6 (-A), codon 
6 (G>A) HbC, codon 6 (A>T) HbS, codon 8 (-AA), 
codon  8/9  (+G),  and  codon  44  (-C),  substitution 
types were codon 15 (G>A) and codon 39 (C>T), 
the exon processing type of RNA splicing mutation 
was codon 27 (G>T) Hb Knossos, the splice junc-
tion change in the 5’ donor site was IVS-1-1 (G>A), 
splice consensus sequence changes in the 5’ donor 
site were IVS-1-5 (G>A), IVS-1-6 (T>C), and IVS-2-1 
(G>A), mutations within exons that affect process-
ing internal IVS change were IVS-1-110 (G>A) and 
IVS-2-745 (C>G), the splice junction change in the 
3’ acceptor site was IVS-1-130 (G>C), the internal 
IVS  change  was  IVS-1-116  (T>G),  and  the  splice 
consensus sequence change in 3’ acceptor site was 
IVS-2-848 (C>A) [9]. 
Results
In all, 22 mutations were investigated in 115 pedi-
atric  patients  with  β-thalassemia.  Whereas  74  of 
patients were not related, 41 were brothers and/or 
sisters. In total, 16 different mutations in 208 alleles 
were identified, and IVS-1-110 (G-A) (29.1%), IVS-1-1 
(G>A)  (13.9%),  codon  (39  (C>T)  (10.4%),  and 
codon 8 (-AA) (9.1%) accounted for 62.5% of all the 
β-thalassemia mutations (Table 1). IVS-1-110 (G>A) 
was the most frequent mutation type in the patients 
from  Şanlıurfa  Province,  as  in  other  geographic 
regions  of  Turkey.  In  all,  76%  of  the  patients  had 
consanguineous parents; 65% of these consanguin-
eous  marriages  were  between  first  cousins. 
β-thalassemia mutations were homozygous in 71.3% 
of the patients, heterozygous in 10.4%, compound 
heterozygous in 4.8%, and undetermined in 9.6%. 
In addition, the following 34 compound hetero-
zygote mutant alleles were observed; IVS-1-1 (G>A)/
IVS-2-848  (n=4),  codon  39  (C>T)/codon  8  (-AA) 
(n=2), codon 6 (-A)/IVS-1-5 (G>C) (n=2), IVS-1-110 
(G>A)/IVS-1-1  (G>A)  (n=2),  IVS-1-110  (G>A)/
codon  8  (-AA)  (n=1),  IVS-1-110  (G>A)/codon  39 
(C>T)  (n=1),  IVS-1-110  (G>A)/IVS-1-6  (T>C) 
(n=1), IVS-1-110 (G>A)/IVS-1-5 (G>C) (n=1), IVS-
1-110 (G>A)/codon 8/9 (+G) (n=1), IVS-1-1 (G>A)/
codon 39 (C>T) (n=1), and codon 8 (-AA)/IVS-1-5 
(G>C) (n=1) (Table 2). The following β-thalassemia 
mutations  were  not  observed;  -101  (C>T),  -87 
(C>T), -30 (T>A), codon 15 (TTG>TGA), codon 27 
(G>T) Knossos, and VS-1-116 (T>G).
Table 1. The Frequency of 22 Different β-thalassemia Mutations in 
230 Alleles
  Homozygote (%)  Heterozygote (%)  Total (%)
IVS-1-110 (G>A)  60 (26.1)  7 (3.0)  67 (29.1)
IVS-1-1 (G>A)   22 (9.6)  10 (4.3)  32 (13.9)
codon 39 (C>T)  18 (7.8)  6 (2.6)  24 (10.4)
codon 8 (-AA)  16 (7.0)  5 (2.2)  21 (9.1)
IVS-1-5 (G>C)  6 (2.6)  4 (1.7)  10 (4.3)
codon 5 (-CD)  8 (3.5)  0  8 (3.5)
codon 44 (-C)  8 (3.5)  0  8 (3.5)
IVS-1-130 (G>C)  8 (3.5)  0  8 (3.5)
codon 8/9 (+G)  4 (1.7)  3 (1.3)  7 (3.0)
IVS-1-130 (G>C)  6 (2.6)  0  6 (2.6)
IVS-1-6 (T>C)  0  5 (2.2)  5 (2.2)
IVS-2-745 (C>G)  4 (1.7)  0  4 (1.7)
IVS-2-848 (C>A)   0  4 (1.7)  4 (1.7)
codon 6 (-A)  0  2 (0.9)  2 (0.9)
codon 6 (G>A) HbC   0  1 (0.4)  1 (0.4)
codon 6 (A>T) HbS  0  1 (0.4)  1 (0.4) 
-110 (C>T)  0  0  0
-87 (C>T)  0  0  0
-30 (T>A)  0  0  0
codon 15 (TTG>TGA)  0  0  0
codon 27 (G>T) Knossos  0  0  0
IVS-1-116 (T>G)   0  0  0
Undetermined  22 (9.6)  NA  22 (9.6)
Total  182  48  230
Table 2. Compound Heterozygous - β-thalassemia Mutations in 
the 115 Pediatric Patients
Mutation 1  Mutation 2  Frequency*
IVS-1-1 (G>A)  IVS-2-848  4
codon 39 (C>T)  codon 8 (-AA)  2
codon 6 (-A)  IVS-1-5 (G>C)  2
IVS-1-110 (G>A)  IVS-1-1 (G>A)  2
IVS-1-110 (G>A)  codon 8 (-AA)  1
IVS-1-110 (G>A)  codon 39 (C>T)  1
IVS-1-110 (G>A)  IVS-1-6 (T>C)  1
IVS-1-110 (G>A)  IVS-1-5 (G>C)  1
IVS-1-110 (G>A)  codon 8/9 (+G)  1
IVS-1-1 (G>A)  codon 39 (C>T)  1
codon 8 (-AA)  IVS-1-5 (G>C)  1
*Number of cases
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β-thalassemia is a serious medical, social, and 
economic problem, both for affected families and 
the general population. To the best of our knowl-
edge all published studies related to β-thalassemia 
mutations are concerned with thalassemia carrier 
status [3-5], and only 2 mutations in children with 
β-thalassemia [8]; as such, the present study is the 
first  to  examine  22  thalassemia  mutations  in  115 
children with β-thalassemia from Şanlıurfa Province, 
Turkey.
Based on a comparison of the frequency of sev-
eral mutations, IVS-1-110 (G-A) is the most common 
mutation in Syria, Macedonia, Greece, and Bulgaria, 
as in the present study (29%), which is nearly half 
the rate previously reported for Turkey [2]. The IVS-
1-1 (G-A) mutation, which is highly prevalent in the 
Marmara and Aegean regions of Turkey, is among 
the  4  most  common  mutations  in  Mediterranean 
and  Middle  Eastern  countries  [8];  in  the  present 
study it was the 2nd most common mutation (14%). 
The order of frequency for other mutations, how-
ever, is different [2,10,11]. There are some differ-
ences between the frequency of mutations observed 
in Şanlıurfa in the present study and that in the near-
est  provinces  Gaziantep  and  Diyarbakir,  e.g.  the 
frequency of codon 39 (C>T) was 10.3%, 3.6%, and 
6.4%, respectively [13].
It was reported that -30 (T>A) mutation, which is 
more common in eastern and southeastern Anatolia 
than other regions [8,12], but its frequency is similar 
to Iran and Syria, was not identified in any mutant 
allele  in  Şanlıurfa,  a  large  city  in  southeastern 
Anatolia. IVS-2-1 (G>A) and codon 8 (-AA) are both 
β-thalassemia mutations associated with mild thal-
assemia, and are the 2 most common mutations in 
Azerbaijan [3]. Patients in the present study that had 
these  mutations  did  not  have  mild  thalassemias, 
and codon 8 (-AA) mutation was the 3rd most com-
mon mutation we observed. IVS-1-130 (G>C) muta-
tions  are  seen  exclusively  in  patients  originating 
from the city of Burdur in the Mediterranean Region 
of  Turkey  and  have  not  been  reported  from  any 
other country [2]. 
In the present study IVS-1-130 (G>C) mutations 
were noted in 6 homozygous alleles. The present 
findings illustrate the heterogeneity of β-thalassemia 
mutations in Şanlıurfa Province, as in other cities in 
Turkey [2]. A broad range of mutations have been 
observed in Turkey, probably because of its location 
at the convergence of 3 continents and the subse-
quent influence of various ethnic groups [13]. The 
consanguineous marriage rate observed among the 
parents of the patients in the present study was 76%, 
which is higher than previously reported [5], where-
as  the  prevalence  of  compound  heterozygous 
β-thalassemia mutations was lower (6%). 
Turkey  has  had  a  national  hemoglobinopathy 
screening program since 2002, known as the Fight 
against  Hereditary  Blood  Disease  [14].  The  pro-
gram’s guidelines were developed for the preven-
tion  and  treatment  of  hemoglobinopathies.  It  is 
estimated  that  150-200  infants  will  be  born  with 
β-thalassemia annually in Turkey [15]. Özdemir et 
al. reported that premarital screening and prenatal 
diagnosis  are  quite  successful  in  preventing  the 
birth of children with thalassemia major in Muğla, 
Turkey [16]. During such screening 131 at-risk cou-
ples were identified and those at risk of having chil-
dren  with  hemoglobinopathy  were  referred  for 
prenatal  diagnosis.  In  all,  75  mothers  underwent 
prenatal diagnosis and 21 were diagnosed with beta 
thalassemia major; in all the cases pregnancy was 
terminated  in  Muğla  [16].  Since  the  start  of  pre-
marital screening in Muğla, there have been no new 
β-thalassemia major births [16]. Conversely, a study 
on  the  efficacy  of  premarital  screening  in  Hatay, 
Turkey, showed that only 17.5% of pregnant high-
risk couples underwent prenatal diagnosis, despite 
receiving  genetic  counseling  [17].  These  results 
show that effectiveness of education in the hemo-
globinopathy  prevention  program  is  inefficient  in 
some province [15]. To the best of our knowledge 
no study related to the effect of Turkey’s hemoglo-
binopathy  screening  program  on  the  rate  of  chil-
dren born with thalassemia has been published. 
Controls  of  new  thalassemic  cases  can  be 
achieved in higher difficulties in Şanlıurfa Province, 
because of the presence of different ethnic groups 
that have large and young families, low socioeco-
nomic and educational status, and as high as 65% 
close consanguineous and common-law marriages. 
Unfortunately,  many  at-risk  couples  still  discover 
their risk only after giving birth to an affected child. 
In addition, at-risk couples find it very difficult to opt 
for  abortion  after  learning  that  their  fetus  has 
β-thalassemia major or other severe diseases. In the 
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years; in all, 53% of the patients were younger than 
8 years and were born after Turkey’s hemoglobin-
opathy screening program began. 
Turkey’s  hemoglobinopathy  screening  program 
must take into account epidemiological and molec-
ular data to set up the adequate strategy that sensiti-
zation and information about the disease, popula-
tion screening and genetic counseling for carriers, 
and  prenatal  diagnosis  for  couples  with  affected 
children. In conclusion, we think that after having 
identified the most frequent mutations in β-thalas-
semia patients from Şanlıurfa Province, the frequen-
cy of premarital, preconception, and prenatal diag-
nosis will increase. 
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